16 Sept 2019
Image: Ermolaev Alexandr / Adobe Stock
Skin and ear conditions are often chronic processes that require long-term management. Owner compliance is crucial for treatment success and costs can become a limiting factor over time.
In dogs presented for a dermatological problem, pruritus is the most common clinical sign, whereas cats commonly present with cutaneous swellings (Hill et al, 2006).
Otitis, pyoderma, anal sac impaction, flea infestation and atopic dermatitis are frequent diagnoses in dogs, whereas abscesses, flea infestation and otitis dominate in cats (Hill et al, 2006). Ideally, the diagnosis is made early on to allow specific, rather than symptomatic, treatment and performing initial diagnostic tests might be more cost-effective in the long run.
This article gives an overview of basic and advanced dermatological workup, and summarises management options for common primary (allergy) and secondary (bacterial and yeast infection/overgrowth) skin diseases.
It is crucial to get a complete history for skin patients as the problem might be ongoing, and a number of previous investigations and treatments might have already been done. It is very true the history reveals a lot of useful information, but might also be time-consuming to acquire.
It might be helpful to have an owner questionnaire in the reception area, which owners can fill in while waiting summarising the most important information (Panel 1). Asking the owner for a numerical “itch and scratch” score (for example, 1 to 10) to rate the severity of pruritus (Colombo et al, 2005; Harvey et al, 2019) is also useful, especially to monitor clinical progression and treatment response between vet visits.
Thorough owner communication is essential to keep good compliance, and owners need to understand most skin conditions are chronic and require frequent follow-up appointments. Seeing the same clinician every time helps with case continuity and saves time reviewing the history.
1. Management
2. Food
3. Contacts
4. General health
5. Skin problem
In a busy practice setting, it is tempting to focus on the obvious lesions and/or owner’s main complaint. However, every dermatological patient should be fully examined in a systematic way by using a “head to tail” approach, including skin folds, paws (interdigital spaces and palmar/plantar aspects) and ventral abdomen. A full clinical examination helps to assess the general health of the patient and establish a differential diagnoses list for the skin complaint.
In-house cytology is a very rewarding, but often underused diagnostic tool in dermatology. It is quick, cost-effective, and gives valuable information about the presence of microorganisms and/or inflammatory cells.
A common scenario would be the allergic patient suffering a flare-up of pruritus, which could be due to the hypersensitivity condition, but also caused by secondary overgrowth/infection with yeast and/or bacteria; this could be readily distinguished on cytology (Figure 1; Bajwa, 2017).
Cytology is very valuable to differentiate between yeast, bacterial or mixed otitis, especially to detect the presence of rod-shaped bacteria, in which case, bacterial culture should be performed.
Repeating cytology at follow-up appointments can give important information about treatment response, whether prolonged therapy is indicated or whether the approach needs to be altered and/or potentially resistant bacteria have emerged, prompting the need for bacterial culture (see further on and Panel 2).
The International Society for Companion Animal Infectious Diseases guidelines (Hillier et al, 2014) give five scenarios when performing bacterial culture is mandatory (Panel 2).
Coat brushings, skin scrapes and hair plucks (trichograms) only require simple and affordable equipment, and should be part of the initial workup in any dermatological case. For example, a trichogram is useful to establish the presence of Demodex species (if a deep skin scrape is not feasible due to lesion location), but also to investigate for other conditions, such as self-inflicted alopecia/over-grooming (presence of broken hair shafts) or dermatophytosis (for example, fungal elements seen within hair shafts).
If even the slightest suspicion of dermatophytosis (clinical lesions can be highly variable, and do not always present as the classic “ring”; Figure 2) exists, fungal culture should be performed and, preferably, submitted to an external laboratory.
Skin biopsies can be useful for inclusion or exclusion of differential diagnoses and ideally to reach a definite diagnosis. However, biopsies are more invasive and costly than other diagnostic tests, and commonly require sedation or general anaesthetic. They should, therefore, be part of a logical workup process, rather than being “the single most informative test”, and timing and lesion selection is important.
Prior to taking skin biopsies, anti-inflammatory medications (especially oral glucocorticoids) should be discontinued for four weeks, and the patient assessed for secondary bacterial pyoderma and treated if needed, unless the patient’s condition does not allow for any delay.
Bacterial infection can significantly mask any underlying pathology and the histopathological changes seen may, therefore, not be representative.
Examples of skin conditions that require histopathological diagnosis include, among others, pemphigoid or lupoid diseases (Figures 3a and 3b), erythema multiforme, hair cycle disorders, sebaceous adenitis or any form of suspected cutaneous neoplasia.
Allergy remains a diagnosis made based on the patient’s history and clinical factors – it cannot be made by laboratory tests (Bajwa, 2018; Hensel et al, 2015; Olivry et al, 2015). It is a diagnosis of exclusion; other differential diagnoses with similar clinical presentation (for example, ectoparasites) need to be ruled out first.
In feline and canine allergic patients, flea allergic dermatitis and cutaneous adverse food reaction (“food allergy”) should be included or excluded prior to testing for environmental allergens.
Some patients suffer from more than one form of allergy – for example, a confirmed cutaneous adverse food reaction does not necessarily exclude atopic dermatitis.
To aid with making the diagnosis of canine atopic dermatitis (CAD), several sets of clinical criteria have been developed.
Most recently, Favrot’s criteria has been published and can be easily applied in practice (Favrot et al, 2010; Panel 3). However, the diagnosis of CAD is multifactorial and should not be based on those factors alone.
Allergy testing for environmental allergens is indicated once the clinical diagnosis of CAD or feline atopy-like dermatitis has been established. The purpose of performing allergen serology and/or intradermal testing is allergen avoidance (wherever possible), and formulation of allergen-specific immunotherapy (ASIT; Bajwa, 2018; Gedon and Mueller, 2018).
Performing strict elimination diet trials for several weeks to test for cutaneous adverse food reaction can be difficult for owners and their pets. Many owners are reluctant to “challenge” their animals with other food stuffs after, as this implies the risk of relapse or deterioration.
Serum testing for food-specific IgG and IgE is available and tempting; however, repeatability is low (Mueller and Olivry, 2017) and studies showing their value in reliably diagnosing “food allergy” are lacking. They might be helpful to choose the components for the food trial.
A strict elimination diet trial with a novel or hydrolysed food, for a minimum period of eight weeks, followed by provocation trials with other food stuffs, remains the gold standard to diagnose cutaneous adverse food reaction.
The allergic patient can often be successfully managed, but rarely cured. Treatment needs to be tailored to the individual, and consists of the combination of long-term measures and acute interventions when flare-ups occur.
The multimodal treatment approach includes symptomatic medications to relieve pruritus and inflammation, disease-modifying treatment (for example, ASIT), management of secondary bacterial, yeast overgrowth and infection, supportive measures to improve the skin barrier and avoidance of flare factors, if possible (Gortel, 2018).
For CAD and feline atopy-like dermatitis, ASIT is the only available disease-modifying treatment and is often recommended to be continued life-long if successful (Gedon and Mueller, 2018). Even though clinical response is slow and treatment success cannot be guaranteed, it might be more cost-effective than frequent symptomatic treatment in the long run.
For owners who are reluctant to consent to frequent SC injections, sublingual immunotherapy (SLIT) might be the more acceptable option. Treatment success rates were comparable in one study (DeBoer and Morris, 2012). SLIT can be successful in some cases that fail to respond to SC ASIT (DeBoer and Morris, 2012).
Sublingual immunotherapy for canine food allergy is an interesting area of research (Maina et al, 2019) and might become available in the future.
In cases of CAD where symptomatic treatment is needed, the main choices with proven clinical efficacy are glucocorticoids, ciclosporin A, oclacitinib and lokivetmab (Gortel, 2018; Olivry et al, 2015). The decision should be made on the individual patient’s needs as they all differ in their mode of action, onset and duration, potential side effects and costs. For example, glucocorticoids might be a good option for fast, initial short-term relief during allergy workup, whereas ciclosporin A might be chosen for patients that require long-term symptomatic treatment after workup has been completed and disease-modifying measures (for example, ASIT) have been unsuccessful or additional medications are needed. Oclacitinib and lokivetmab can be used for short-term and long-term management, but should not replace the initial workup.
All the aforementioned can be complemented by supportive therapies (for example, essential fatty acids or hypoallergenic shampoos).
Bacterial and yeast overgrowth, and infection, should always be considered secondary to an underlying pathology.
With the emergence of bacterial resistance, topical products are a valuable alternative to systemic treatment. Whenever possible, topical antimicrobial treatment is favoured over oral antibiotics and is usually well-tolerated.
Topical therapy is recommended as a single treatment for surface and superficial infections, especially for cases with meticillin-resistant Staphylococcus species (Morris et al, 2017).
One study has shown twice-weekly bathing with a 4% chlorhexidine digluconate shampoo in combination with daily 4% chlorhexidine digluconate solution was as effective as a course of oral amoxicillin-clavulanic acid over a four-week period (Borio et al, 2015).
Besides chlorhexidine-containing products, other antimicrobial topical treatments (for example, hypochlorous acid) are available and licensed for animal use.
In topical therapy, several factors (for example, presence of localised or generalised lesions, frequency of application, owner compliance, and the patient’s temperament and tolerance) contribute to therapeutic success.
Topical therapy can be maintained long-term to prevent relapses of overgrowth/infection (for example, antimicrobial shampoo therapy or ear cleaning) and might be less costly over time than repeated courses of systemic antimicrobial treatment.
Dermatological conditions are often chronic and can frequently be managed, but not cured. Good owner communication and compliance is crucial for treatment success.
Aiming for further workup and a clear diagnosis early on is beneficial, not only for the patient’s welfare and disease management, but also cost-effective in the long term.
Jeanette Bannoehr
Job Title